| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/CARCIN/15.2.177 |
| P698 | PubMed publication ID | 8313505 |
| P50 | author | Paul Talalay | Q16736446 |
| P2093 | author name string | T W Kensler | |
| P A Egner | |||
| T J Curphey | |||
| T Prestera | |||
| A H Libby | |||
| H H Joyner | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 177-181 | |
| P577 | publication date | 1994-02-01 | |
| P1433 | published in | Carcinogenesis | Q326022 |
| P1476 | title | Regulation of phase 2 enzyme induction by oltipraz and other dithiolethiones | |
| P478 | volume | 15 |
| Q37196960 | 5,6-Dihydrocyclopenta[c][1,2]-dithiole-3(4H)-thione is a promising cancer chemopreventive agent in the urinary bladder. |
| Q43670622 | Antimutagenic activity of organosulfur compounds from Allium is associated with phase II enzyme induction |
| Q41191860 | Antioxidant-inducible genes |
| Q36419978 | Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase). |
| Q34638753 | Chemoprevention by inducers of carcinogen detoxication enzymes |
| Q53434529 | Chemopreventive activity of oltipraz. |
| Q53410058 | Chemoprotective 3H-1,2-dithiole-3-thione induces antioxidant genes in vivo. |
| Q71699408 | Correlations between n-octanol/water partition coefficients and RP-HPLC capacity factors of 1,2-dithiole-3-thiones and 1,2-dithiol-3-ones |
| Q36695850 | Dietary induction of NQO1 increases the antitumour activity of mitomycin C in human colon tumours in vivo |
| Q37002516 | Dithiolethiones for cancer chemoprevention: where do we stand? |
| Q64789910 | Drug treatment of Parkinson's disease. Time for phase II |
| Q77668679 | Drug-metabolizing enzyme induction by 2,2'-dipyridyl, 1,7-phenanthroline, 7,8-benzoquinoline and oltipraz in mouse |
| Q40785972 | Effect of chemopreventive agents on DNA adduction induced by the potent mammary carcinogen dibenzo[a,l]pyrene in the human breast cells MCF-7. |
| Q58750322 | Effects of C2-Ceramide and Oltipraz on Hepatocyte Nuclear Factor-1 and Glutathione S-Transferase A1 in Acetaminophen-Mediated Acute Mice Liver Injury |
| Q28569268 | Effects of lead on rat kidney and liver: GST expression and oxidative stress |
| Q28367745 | Electrophile and antioxidant regulation of enzymes that detoxify carcinogens |
| Q36618045 | Enhanced cytotoxicity of mitomycin C in human tumour cells with inducers of DT-diaphorase |
| Q34278223 | Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element-like sequences in the nrf2 promoter |
| Q42502343 | Factors influencing the induction of DT-diaphorase activity by 1,2-dithiole-3-thione in human tumor cell lines |
| Q40473981 | Gene Structure at the Human UGT1 Locus Creates Diversity in Isozyme Structure, Substrate Specificity, and Regulation |
| Q40849635 | Glutathione S-transferases--biomarkers of cancer risk and chemopreventive response |
| Q37371494 | Hydrogen peroxide is a second messenger in phase 2 enzyme induction by cancer chemopreventive dithiolethiones |
| Q35147430 | Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis |
| Q78232689 | Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives |
| Q28383023 | Induction of DT-diaphorase by 1,2-dithiole-3-thione and increase of antitumour activity of bioreductive agents |
| Q36292457 | Induction of DT-diaphorase by 1,2-dithiole-3-thiones in human tumour and normal cells and effect on anti-tumour activity of bioreductive agents |
| Q35718471 | Induction of NQO1 in cancer cells |
| Q50139383 | Inhibition of covalent DNA binding and mutagenicity of benzo[a]pyrene by isopropyl-2-(1,3-dithietane-2-ylidene)-2-[N-(4-methylthiazol-2-yl) carbamoyl]acetate (YH439), a novel hepatoprotective agent. |
| Q33815474 | Interactions of the major metabolite of the cancer chemopreventive drug oltipraz with cytochrome c: a novel pathway for cancer chemoprevention |
| Q33709242 | Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacy |
| Q33538223 | Modeling the chemoprotective functions of glutathione S-transferases in cultured cell lines by heterologous expression |
| Q37359368 | Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz |
| Q35586131 | NAD(P)H:quinone oxidoreductase 1 Arg139Trp and Pro187Ser polymorphisms imbalance estrogen metabolism towards DNA adduct formation in human mammary epithelial cells |
| Q44564177 | Oltipraz inhibits 3-methylcholanthrene induction of CYP1A1 by CCAAT/enhancer-binding protein activation |
| Q28377545 | Organ-dependent modifying effects of oltipraz on N-nitrosobis(2-oxopropyl)amine (BOP)-initiation of tumorigenesis in hamsters |
| Q40655496 | Oxathiolene oxides: a novel family of compounds that induce ferritin, glutathione S-transferase, and other proteins of the phase II response |
| Q28378816 | Parallel induction of heme oxygenase-1 and chemoprotective phase 2 enzymes by electrophiles and antioxidants: regulation by upstream antioxidant-responsive elements (ARE) |
| Q42540518 | Protective effects of anethole dithiolethione against oxidative stress-induced cytotoxicity in human Jurkat T cells |
| Q41703164 | Redox regulation of genes that protect against carcinogens |
| Q35718483 | Role of nicotinamide quinone oxidoreductase 1 (NQO1) in protection against toxicity of electrophiles and reactive oxygen intermediates |
| Q34338156 | Role of phase 2 enzyme induction in chemoprotection by dithiolethiones |
| Q44485480 | Role of the AP-1 element and redox factor-1 (Ref-1) in mediating transcriptional induction of DT-diaphorase gene expression by oltipraz: a target for chemoprevention |
| Q28386244 | Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents |
| Q44528897 | Spray-dried redispersible oil-in-water emulsion to improve oral bioavailability of poorly soluble drugs |
| Q35718429 | The "Prochaska" microtiter plate bioassay for inducers of NQO1. |
| Q37793795 | Transactivation of Genes Encoding for Phase II Enzymes and Phase III Transporters by Phytochemical Antioxidants |
Search more.